Actas Urológicas Españolas (English Edition)

ISSN: 2173-5786

Actas Urológicas Españolas is an international journal dedicated to urological diseases and renal transplant. It has been the official publication of the Spanish Urology Association since 1974 and of the American Urology Confederation since 2008. Its articles cover all aspects related to urology.
Actas Urológicas Españolas, governed by the peer review system (double blinded), is published online in Spanish and English. Consequently, manuscripts may be sent in Spanish or English and bidirectional free cost translation will be provided. It has high visibility and accessibility and is found in the most important data bases, Medline/Pubmed, Emabase, JCR, Ïndice Médico Español, Índice bibliográfico Español en Ciencias de la Salud (IBECS), Cuiden, Dialnet, Hinari, Scopus, Google Scholar.

See more Open Access Option

Indexed in:

Medline

Subscribe:

Impact factor

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years.

© Clarivate Analytics, Journal Citation Reports 2025

Impact factor 2024

1.2

Citescore

CiteScore measures average citations received per document published.

Citescore 2024

2.2

SJR

SRJ is a prestige metric based on the idea that not all citations are the same. SJR uses a similar algorithm as the Google page rank; it provides a quantitative and qualitative measure of the journal's impact.

SJR 2024

0.440

SNIP

SNIP measures contextual citation impact by wighting citations based on the total number of citations in a subject field.

SNIP 2024

0.628

View more metrics

Journal Information

Urothelial Carcinoma: Updating the latest developments

Edited by Andrea Gallioli Fundació Puigvert
Marco Moschini San Raffaele Hospital

Last update: June 2025

Urothelial carcinoma has presented important advances in diagnosis and treatment in recent years. This monographic issue published by the YAU-EAU urothelial cancer group updates diagnosis and follow-up using epicheck and ctDNA, new intravesical treatments based on the FGFR mutation, and results from real-life hyperthermia studies.

Novel risk factors for venous thromboembolism following outpatient or inpatient transurethral resection of bladder tumors: Multivariable stepwise and LASSO regression modeling from us insurance claim database

J. Łaszkiewicz, F. Del Giudice, S. Li, W. Krajewski, Ł. Nowak, T. Szydełko, S. Basran, E. De Berardinis, ... B.I. Chung

Actas Urol Esp. 2025;49:

Full text access

Open Article

Twitter

Facebook

Radiofrequency induced hyperthermia in non-muscle invasive bladder cancer: Oncologic outcomes in a real-world scenario

S. Mero, K. Oberneder, J. Weiss, E. Grobet-Jeandin, A. Grégoris, P. Sèbe, S. Shariat, D. D’Andrea

Actas Urol Esp. 2025;49:

Full text access

Open Article

Twitter

Facebook

Real-life perception of pathology reports in urology

A. Cimadamore, M. Moschini, J. Teoh, S. Albisinni, Z. Adwin, W. Shen Ta, K. Mori, M. Wroclawski, ... en representación del Grupo de Trabajo de Carcinoma Urotelial de la Sección de Jóvenes Urólogos Académicos - Asociación Europea de Urología (EAU-YAU)

Actas Urol Esp. 2025;49:

Twitter

Facebook

Diagnostic accuracy of Bladder EpiCheck for upper tract urothelial carcinoma: A meta-analysis

S. Artero Fullana, J. Caño Velasco, A. Lafuente Puentedura, L. Polanco Pujol, V. Bataller Monfort, M. Moralejo Gárate, J.D. Subiela, A. Gallioli, ... en representación del Grupo de Trabajo de Carcinoma Urotelial de la Sección de Jóvenes Urólogos Académicos - Asociación Europea de Urología (EAU-YAU)

Actas Urol Esp. 2025;49:

Twitter

Facebook

The impact of a multidisciplinary approach on treatment decisions and outcomes in urothelial carcinoma: A systematic review

E. Albers Acosta, L. Pelari-Mici, G. Celada Luis, C. Velasco Balanza, A. Zapatero, N. Romero-Laorden, P. Toquero Diez, J. Caño-Velasco, ... en representación del Grupo de Trabajo de Carcinoma Urotelial de la Sección de Jóvenes Urólogos Académicos - Asociación Europea de Urología (EAU-YAU)

Actas Urol Esp. 2025;49:

Twitter

Facebook

Circulating tumor DNA in muscle-invasive bladder cancer: A systematic review

A.A. Grosso, A. Cadenar, S. Pillozzi, G. Carli, F. Lipparini, F. Di Maida, R. Pichler, W. Krajewski, ... en representación del Grupo de Trabajo de Carcinoma Urotelial de la Sección de Jóvenes Urólogos Académicos - Asociación Europea de Urología (EAU-YAU)

Actas Urol Esp. 2025;49:

Full text access

Open Article

Twitter

Facebook

Oncological outcomes of patients with node positive disease following neoadjuvant chemotherapy and radical cystectomy for muscle-invasive bladder cancer: A multicenter observational study of the EAU Young Academic Urologists (YAU) urothelial carcinoma working group

G. Marcq, W. Kassouf, M. Roumiguié, B. Pradere, L.S. Mertens, S. Albisinni, A. Cimadamore, J. Yuen-Chun Teoh, ... G. Ploussard

Actas Urol Esp. 2025;49:

Full text access

Open Article

Twitter

Facebook

Biological and therapeutic implications of FGFR alterations in urothelial cancer: A systematic review from non-muscle-invasive to metastatic disease

R. Pichler, N.C.H. van Creij, J.D. Subiela, A. Cimadamore, J. Caño-Velasco, K.H. Tully, K. Mori, R. Contieri, ... Asociación Europea de Urología-Jóvenes Urólogos Académicos (EAU-YAU): Grupo de Trabajo de Carcinoma Urotelial

Actas Urol Esp. 2025;49:

Full text access

Open Article

Twitter

Facebook

Publish in

Actas Urológicas Españolas

Actas Urológicas Españolas (English Edition) is a member and subscribes the principles of, the Committee on Publication Ethics (COPE)
www.publicationethics.org.

Free access articles

Circulating tumor DNA in muscle-invasive bladder...

Actas Urol Esp. 2025;49:

Radiofrequency induced hyperthermia in non-muscle invasive...

Actas Urol Esp. 2025;49:

User profile and engagement with a digital health...

Actas Urol Esp. 2025;49:

Biological and therapeutic implications of FGFR alterations...

Actas Urol Esp. 2025;49:

Indexed in:

Follow us:

Subscribe:

Urothelial Carcinoma: Updating the latest developments

Subscribe to our newsletter